MIT LFE with Informa Pharma Intelligence launches project ALPHA

The MIT Laboratory for Financial Engineering (LFE) and Informa Pharma Intelligence announced Project ALPHA (Analytics fo...

January 7, 2019 | Monday | News
Ribon Therapeutics raises $65M

Ribon Therapeutics, a biotechnology company developing first-in-class therapeutics targeting novel enzyme families activ...

January 7, 2019 | Monday | News
Green Leaf Medical raises $20M for expansion

Green Leaf Medical, LLC, a MSO (Multi-State Operator) of medical cannabis facilities in the Northeast United S...

January 7, 2019 | Monday | News
MD Anderson Cancer Centre, 4D pharma collaborate to evaluate live biotherapeutics in solid tumors

The University of Texas MD Anderson Cancer Centre and 4D pharma has announced a strategic collaboration to evaluate...

January 7, 2019 | Monday | News
Ironwood Pharma appoints Michael Shetzline as CMO

Ironwood Pharmaceuticals, Inc. has announced that Michael Shetzline, M.D., Ph.D., will join Ironwood as chief medical of...

January 7, 2019 | Monday | News
Bristol-Myers Squibb to acquire Celgene

Bristol-Myers Squibb Company and Celgene Corporation has announced that they have entered into a definitive merger agree...

January 4, 2019 | Friday | News
J&J, Locus Bioscience collaborate to develop CRISPR-Cas3 bacteriophage therapeutics

Locus Biosciences Inc., a biotechnology company developing precision antibacterial therapies, announced today that it ha...

January 4, 2019 | Friday | News
Generex Biotechnology partners with Olaregen Therapeutix

Generex Biotechnology Corporation has announced that its partially, soon to be fully-owned subsidiary, Olaregen Therapeu...

January 4, 2019 | Friday | News
AstraZeneca’s Bevespi Aerosphere approved in the EU

AstraZeneca has announced that the European Commission (EC) has approved Bevespi Aerosphere (glycopyrronium/formote...

January 3, 2019 | Thursday | News
ImaginAb Announces Strengthening of Board and Executive Leadership Team

ImaginAb,  a clinical stage immuno-oncology imaging company has announced the appointment of Friedhelm Blobel, Ph.D...

January 3, 2019 | Thursday | News
Correvio Announces Chief Executive Officer Succession Plan

Correvio Pharma Corp, a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs h...

January 3, 2019 | Thursday | News
USFDA approves Portola Pharmaceuticals’ Andexxa®

Portola Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved the Company’s ...

January 3, 2019 | Thursday | News
FDA approves Sanofi & MSD’s VAXELIS™

The U.S. Food and Drug Administration has approved VAXELIS™ (Diphtheria and Tetanus Toxoids and Acellular Pertussi...

January 3, 2019 | Thursday | News
AstraZeneca announces phase III trials for roxadustat

AstraZeneca has announced that the Phase III OLYMPUS and ROCKIES trials for roxadustat each met their primary efficacy e...

January 3, 2019 | Thursday | News
AI predicts cancer patients’ symptoms

Doctors could get a head start treating cancer thanks to new AI developed at the University of Surrey that is able to pr...

January 2, 2019 | Wednesday | News
Alexion receives early FDA approval For ULTOMIRIS

Alexion Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved ULTOMIRIS&trad...

January 2, 2019 | Wednesday | News
PolarityTE registers OsteoTE™ with USFDA

PolarityTE, Inc., a commercial-stage biotechnology company focused on transforming the lives of patients by discovering,...

January 2, 2019 | Wednesday | News
George A. Williams to work as 123rd President of the AAO

George A. Williams, M.D, today begins his term as the 123rd president of the American Academy of Ophthalmology (AAO). Dr...

January 1, 2019 | Tuesday | News